Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Improved Insulin Sensitivity on Bone Turnover and Bone Properties in Type 2 Diabetes Mellitus
2019-003771-19Phase 4Terminated
- Sponsor
- Aarhus University Hospital
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by Aarhus University Hospital. Primary endpoint: Bone turnover markers in blood. Started Oct 2019; status: terminated.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2019-003771-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003771-19.